Results 11 to 20 of about 641,320 (378)

Chemistry, structure and function of approved oligonucleotide therapeutics

open access: yesNucleic Acids Research, 2023
Eighteen nucleic acid therapeutics have been approved for treatment of various diseases in the last 25 years. Their modes of action include antisense oligonucleotides (ASOs), splice-switching oligonucleotides (SSOs), RNA interference (RNAi) and an RNA ...
M. Egli, M. Manoharan
semanticscholar   +1 more source

Delivery of oligonucleotide‐based therapeutics: challenges and opportunities

open access: yesEMBO Molecular Medicine, 2021
Nucleic acid‐based therapeutics that regulate gene expression have been developed towards clinical use at a steady pace for several decades, but in recent years the field has been accelerating.
S. Hammond   +21 more
semanticscholar   +1 more source

Oligonucleotide Therapeutics: From Discovery and Development to Patentability

open access: yesPharmaceutics, 2022
Following the first proof of concept of using small nucleic acids to modulate gene expression, a long period of maturation led, at the end of the last century, to the first marketing authorization of an oligonucleotide-based therapy.
L. Moumné   +2 more
semanticscholar   +1 more source

Recent Advances in Oligonucleotide Therapeutics in Oncology

open access: yesInternational Journal of Molecular Sciences, 2021
Cancer is one of the leading causes of death worldwide. Conventional therapies, including surgery, radiation, and chemotherapy have achieved increased survival rates for many types of cancer over the past decades.
Haoyu Xiong   +2 more
semanticscholar   +1 more source

Antisense oligonucleotides [PDF]

open access: yesNeurology Genetics, 2019
There are few disease-modifying therapeutics for neurodegenerative diseases, but successes on the development of antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy and Duchenne muscular dystrophy predict a robust future for ASOs in medicine.
Scoles, Daniel R.   +2 more
openaire   +2 more sources

The role of SAXS and molecular simulations in 3D structure elucidation of a DNA aptamer against lung cancer

open access: yesMolecular Therapy: Nucleic Acids, 2021
Aptamers are short, single-stranded DNA or RNA oligonucleotide molecules that function as synthetic analogs of antibodies and bind to a target molecule with high specificity.
Dmitry Morozov   +18 more
doaj   +1 more source

Development of a sensitive ELISA to quantify apolipoprotein CIII in nonhuman primate serum

open access: yesJournal of Lipid Research, 2011
Apolipoprotein CIII (apoCIII), a major constituent of triglyceride-rich lipoprotein, has been proposed as a key contributor to hypertriglyceridemia on the basis of its inhibitory effects on lipoprotein lipase.
Yuxin Wang   +4 more
doaj   +1 more source

Physico-chemical foundations underpinning microarray and next-generation sequencing experiments [PDF]

open access: yes, 2013
Hybridization of nucleic acids on solid surfaces is a key process involved in high-throughput technologies such as microarrays and, in some cases, next-generation sequencing (NGS).
A. Buhot   +70 more
core   +8 more sources

Pharmacological Characterization of a Novel ENaCα siRNA (GSK2225745) With Potential for the Treatment of Cystic Fibrosis

open access: yesMolecular Therapy: Nucleic Acids, 2013
Lung pathology in cystic fibrosis is linked to dehydration of the airways epithelial surface which in part results from inappropriately raised sodium reabsorption through the epithelial sodium channel (ENaC).
Kenneth L Clark   +23 more
doaj   +1 more source

Oligonucleotide-capped nanoporous anodic alumina biosensor as diagnostic tool for rapid and accurate detection of Candida auris in clinical samples

open access: yesEmerging Microbes and Infections, 2021
Candida auris has arisen as an important multidrug-resistant fungus because of several nosocomial outbreaks and elevated rates of mortality. Accurate and rapid diagnosis of C.
Luis Pla   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy